Statements (33)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:approvalYear |
2005
|
| gptkbp:ATCCode |
C01EB17
|
| gptkbp:brand |
Coralan
Ivabradex Lancora |
| gptkbp:CASNumber |
155117-17-4
|
| gptkbp:chemicalFormula |
C27H36N2O5S
|
| gptkbp:contraindication |
gptkb:acute_myocardial_infarction
gptkb:sick_sinus_syndrome severe hypotension |
| gptkbp:effect |
reduces heart rate
|
| gptkbp:eliminationHalfLife |
2 hours
|
| gptkbp:excretion |
urine
feces |
| gptkbp:genericName |
ivabradine
|
| https://www.w3.org/2000/01/rdf-schema#label |
Procoralan
|
| gptkbp:legalStatus |
Rx-only
|
| gptkbp:manufacturer |
gptkb:Servier
|
| gptkbp:mechanismOfAction |
inhibits If current in the sinoatrial node
|
| gptkbp:metabolism |
liver
|
| gptkbp:molecularWeight |
468.65 g/mol
|
| gptkbp:pregnancyCategory |
not recommended
|
| gptkbp:prescriptionStatus |
prescription only
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
dizziness
bradycardia phosphenes |
| gptkbp:status |
approved in EU
|
| gptkbp:usedFor |
gptkb:stable_angina
chronic heart failure |
| gptkbp:bfsParent |
gptkb:Servier_Laboratories
|
| gptkbp:bfsLayer |
7
|